Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety Study.
about
Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention.Bloodless management of benign prostatic hyperplasia: medical and minimally invasive treatment options.Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues.High-grade prostatic intraepithelial neoplasia.Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia.DNA methyl transferase 1 reduces expression of SRD5A2 in the aging adult prostateEffects of preoperative dutasteride treatment in holmium laser enucleation of the prostate.Precursor lesions of prostate cancer.The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer.Targeted therapy of cancer: new roles for pathologists--prostate cancer.High-grade prostatic intraepithelial neoplasia of the prostate: the precursor lesion of prostate cancer.Precursors of prostate cancer.Reduced levels of 5-α reductase 2 in adult prostate tissue and implications for BPH therapy.Do all patients with high-grade prostatic intraepithelial neoplasia on initial prostatic biopsy eventually progress to clinical prostate cancer?Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy.Gleason grading controversies: what the chemoprevention trials have taught us.Benign prostatic hyperplasia: caveat for finasteride should be discussed before prescribing.Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.
P2860
Q33658285-49F3842B-673B-43D9-8A88-A88EB0A3AB59Q33797223-C781D35A-4B3D-4E30-80ED-958A4679EC86Q34064040-8DAF0A20-8758-4C13-9B0C-52EE36EA4712Q34291962-328378C6-324C-4C38-8CA0-17E4D6375630Q34696497-9C9E17C7-5687-4AD1-AA41-738BC9DD82BBQ35143766-44F99B7D-CFA2-46BC-856A-405382F1FC50Q35550950-7E303A3C-32EE-49CC-8F8E-29A8B525C2A4Q36799466-1A8C6546-D590-4C70-A94A-32695685ADBAQ37086672-CBA5BB15-383D-4F2B-B758-A08DDC6282E6Q37147772-C5179B3C-946C-4064-B045-3F445424FE02Q37374251-18F43123-A08A-4044-AB62-4BA9C1F4C759Q37972697-E4EE9BA7-B51C-4CC5-ADB3-92365754A714Q39594981-1559A587-23C6-4C9D-9D61-00DB8F3FEFBFQ39724593-B3A700A8-1A4A-48CA-955A-148F90D275A4Q41947729-4AED4F5E-3761-4E34-8C30-FF2F08344745Q43109397-99ED1FC5-5A1E-4273-B31F-AACD207C8950Q43252347-42850E60-7C09-4FC1-BBD2-F1F16834B552Q45784694-348C080D-37A2-4A79-B0C8-4AA42E7F0F0FQ46200270-14138DE2-2DE1-44C4-8FD3-0E1984AEF694
P2860
Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety Study.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Does long-term finasteride the ...... erm Efficacy and Safety Study.
@ast
Does long-term finasteride the ...... erm Efficacy and Safety Study.
@en
type
label
Does long-term finasteride the ...... erm Efficacy and Safety Study.
@ast
Does long-term finasteride the ...... erm Efficacy and Safety Study.
@en
prefLabel
Does long-term finasteride the ...... erm Efficacy and Safety Study.
@ast
Does long-term finasteride the ...... erm Efficacy and Safety Study.
@en
P2093
P1433
P1476
Does long-term finasteride the ...... erm Efficacy and Safety Study.
@en
P2093
Epstein JI
Gottesman J
Lecksell K
Peterson L
Schellhammer PF
P304
P356
10.1016/S0090-4295(98)00579-2
P407
P577
1999-04-01T00:00:00Z